Moderate-high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis.

Foong YC, Merlo D, Gresle M, Buzzard K, Horakova D, Havrdova EK, Kalincik T, Roos I, Hodgkinson S, Lechner-Scott J, Lugaresi A, Weinstock-Guttman B, Ozakbas S, Surcinelli A, Foschi M, Boz C, Khoury SJ, Yamout B, Laureys G, Blanco Y, Skibina O, Kuhle J, John N, Alroughani R, Prevost J, Van Pesch V, Tomassini V, Prat A, Girard M, Terzi M, Shaygannejad V, Ampapa R, Gray O, Etemadifar M, Guimarães J, McCombe PA, Gerlach O, Solaro C, Butzkueven H, Zhu C, van der Walt A, Study Group M

Open source

DOI: 10.1136/jnnp-2025-336513
Published: 2025 Dec 12
Container: Journal of neurology, neurosurgery, and psychiatry
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/jnnp-2025-336513,
  title = {Moderate-high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis.},
  author = {Foong YC and Merlo D and Gresle M and Buzzard K and Horakova D and Havrdova EK and Kalincik T and Roos I and Hodgkinson S and Lechner-Scott J and Lugaresi A and Weinstock-Guttman B and Ozakbas S and Surcinelli A and Foschi M and Boz C and Khoury SJ and Yamout B and Laureys G and Blanco Y and Skibina O and Kuhle J and John N and Alroughani R and Prevost J and Van Pesch V and Tomassini V and Prat A and Girard M and Terzi M and Shaygannejad V and Ampapa R and Gray O and Etemadifar M and Guimarães J and McCombe PA and Gerlach O and Solaro C and Butzkueven H and Zhu C and van der Walt A and Study Group M},
  year = {2025},
  journal = {Journal of neurology, neurosurgery, and psychiatry},
  doi = {10.1136/jnnp-2025-336513},
  url = {https://doi.org/10.1136/jnnp-2025-336513}
}

RIS

TY  - JOUR
TI  - Moderate-high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis.
AU  - Foong YC
AU  - Merlo D
AU  - Gresle M
AU  - Buzzard K
AU  - Horakova D
AU  - Havrdova EK
AU  - Kalincik T
AU  - Roos I
AU  - Hodgkinson S
AU  - Lechner-Scott J
AU  - Lugaresi A
AU  - Weinstock-Guttman B
AU  - Ozakbas S
AU  - Surcinelli A
AU  - Foschi M
AU  - Boz C
AU  - Khoury SJ
AU  - Yamout B
AU  - Laureys G
AU  - Blanco Y
AU  - Skibina O
AU  - Kuhle J
AU  - John N
AU  - Alroughani R
AU  - Prevost J
AU  - Van Pesch V
AU  - Tomassini V
AU  - Prat A
AU  - Girard M
AU  - Terzi M
AU  - Shaygannejad V
AU  - Ampapa R
AU  - Gray O
AU  - Etemadifar M
AU  - Guimarães J
AU  - McCombe PA
AU  - Gerlach O
AU  - Solaro C
AU  - Butzkueven H
AU  - Zhu C
AU  - van der Walt A
AU  - Study Group M
PY  - 2025
JO  - Journal of neurology, neurosurgery, and psychiatry
DO  - 10.1136/jnnp-2025-336513
UR  - https://doi.org/10.1136/jnnp-2025-336513
ER  -

APA

YC, F., D, M., M, G., K, B., D, H., EK, H., T, K., I, R., S, H., J, L., A, L., B, W., S, O., A, S., M, F., C, B., SJ, K., B, Y., G, L., Y, B., O, S., J, K., N, J., R, A., J, P., V, V. P., V, T., A, P., M, G., M, T., V, S., R, A., O, G., M, E., J, G., PA, M., O, G., C, S., H, B., C, Z., A, V. D. W., & M, S. G. (2025). Moderate-high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis.. Journal of neurology, neurosurgery, and psychiatry. https://doi.org/10.1136/jnnp-2025-336513

Source records

pubmed · retrieved 2026-09-25T14:47:29.088Z
europe-pmc · retrieved 2026-09-25T14:47:29.113Z